Alessandra Curioni Fontecedro
231 works · 7,305 citations · h-index 35
Top works
- Sotorasib for Lung Cancers with KRAS p.G12C Mutation
- Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
- Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma
- Targeted Therapy for Patients with BRAF-Mutant Lung Cancer Results from the European EURAF Cohort
- How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere
- A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
- Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial
- Frequent PD-L1 expression in testicular germ cell tumors
- A new era of oncology through artificial intelligence
- Particle size and activation threshold: a new dimension of danger signaling
- Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks – Initial results
- Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program
- Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
- [18F]FDG uptake of axillary lymph nodes after COVID-19 vaccination in oncological PET/CT: frequency, intensity, and potential clinical impact
- Genomic landscape of pleural and peritoneal mesothelioma tumours
- Diffuse pseudoprogression in a patient with metastatic non-small-cell lung cancer treated with Nivolumab
- Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer
- Targeting the mTOR Complex by Everolimus in NRAS Mutant Neuroblastoma
- STRN-ALK Rearranged Malignant Peritoneal Mesothelioma With Dramatic Response Following Ceritinib Treatment
- 18F-FDG PET/CT of Non–Small Cell Lung Carcinoma Under Neoadjuvant Chemotherapy: Background-Based Adaptive-Volume Metrics Outperform TLG and MTV in Predicting Histopathologic Response